Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Temuchin why is oddo still listed? You said earlier is a good question if the website is up to date why are they on it but not on the Rns's? What is their role.
P.s. Destroying the sp is not an acceptable role or answer.(((((
LinkedIn announcing todays RNS.
One member responded with:
"Why did you let the share price drop from 13 EUR to 3,75 EUR encouraging shareholders to buy by saying you're on your way to become a midcap, be patient, no news is good news ? Why do you remain silent since then ?"
- At least it's out there.
Another poor RNS
From todays RNS -
"it will address the most prominent [questions] within the confines of information already disclosed to the market through regulatory notifications."
+++
Is this the company planning a meaningful RNS at some time before the meeting, that the board decide is all they want to discuss, - whilst we are expecting meaningful answers to our most prominent questions.
Poidster, they can't divulge price sensitive information during the meeting. There's nothing to prevent it being announced prior though. They must surely realize that the dispute is the single biggest issue concerning shareholders at the moment. To hold this meeting and seek to dodge or ignore this issue will not go down well at all. I have to hope they have this much self awareness.
I dont think the meeting will reverse our declines, what the market needs is a beluef that revenues 2, 3 and 5 years out are assured. Hopefully we will learn of that soon.
If it had been resolved they would have to announce that when it happened as market sensitive info.
btw there is a FOI response on the question expected next week 11 Aug https://www.whatdotheyknow.com/request/novacyt_dispute
*things
I'd like to think, they will use this presentation to announce a satisfactory resolution to the DHSC dispute and DA will be the one to announce it, would make a sizeable impression at the start of his tenure.
Stranger thanks have happened.
Appointing ODDO was a disaster (is a disaster?) - So what's the story, and how did it go wrong.
- Does the answer show why France is such a poor market for us?
Bluelight, on reflection you are correct, my question was just a swipe at the french not backing their own company.
Why would we care about France, it's not a major market for us. It's been made plainly clear the US market is where we are expanding and targeting. Surely the questions should be about that massive market opportunity and not a backwater like france.
Key question, do we expect significant sales in France and if not why not?
If we don't ask the juiciest questions, no-one will be able to say the board cherry picked only the easiest questions to answer.
If the Chairman doesn't think Novacyt is working with ODDO any more, that information (and the reason why) should be public knowledge, - ODDO not being mentioned in the chairman's statement was not an omission IMO.
Yes Lewis, it's still a farce.
I am very disappointed with the management's behavior.
I would have liked a nice stock market story. But again, we get screwed ....
@Soder
You should certainly ask all those questions
Any question that is important to know by the investor send it in for sure.
@Kaeren
Thanks, mind you a friend of mine owns a Contract Cleaning company in Staffordshire and he's done incredibly well with it. As the saying goes "Where's there's muck there's money"
GLA
Not just a nibble at the SP today now, more of a small bite!
Come on Nova ffs..
True Wilson, - all the more reason for these beans to be spilled.
In the spilling, I want to know everything unvarnished, - that way we might be able to see conflicting PoV in the board members, or Franco - German interest.
Interested in Jean-Pierre Crinelli here.
One question we should all ask and force a response to is:
In light of current M&A in the diagnostics sector do management and the board agree that our valuation places us as a potential acquisition target? Indeed, can management confirm if you have ever received any inbound enquiry with regards to M&A? Lastly, If management can’t get the share price to a level which reflects ncyt fundamental value do you agree that a strategic review should be undertaken with the possibility that the business is placed for sale in order to maximise shareholder value.
Frustrating, the share price is just being nibbled at day by day, so small that you have to look at the six month chart to really see it.
I am really surprised with the amount of tests they must be selling there is nothing new they can RNS to give the SP a jolt.
We now need a 10% rise just to get back to £3.50.
Frustrating but more patience needed and still expecting September to be the turning point.
B2 with my tongue ever so slightly in my cheek when were ODDO ever working for us, that's a nice one to clear up.
correction:
ODDO appointed on 28th September 2020
Annual Report and Accounts for the year ended 31 December 2020
Chairmans Statement page 13
We are delighted to be working with Allegra Finance as our French listing sponsor,
SP Angel Corporate Finance LLP as our Nominated Adviser/ Broker,
and added Numis as well during 2020.
++++
ODDO was also added in 2020, but since the French listing Sponsor gets a mention, but ODDO does not,
I am inclined to think ODDO can consider themselves sacked.
++++
I shall be asking the questions
1 If ODDO appointed on 28th September via RNS, and the above appears to imply ODDO no longer appointed,
why no RNS confirmation.
2 Why is ODDO no longer working on Novacyt's behalf
I'm hoping that if the company doesn't think its important enough to RNS then its ok to discuss at this meeting.
Perhaps we wont get a detailed breakdown of figures but at least we can ask why?
If nothing else at least this is a PLUS point in the communications area
Hopefully well get a flavour of what the New CEO wants/hopes to deliver, and perhaps of how other Markets are expanding USA/Asia/Middle East / Fi tt oFly /Travel/Schools/Universities Versalab etc
Valju read your 7.26 post again hence my reply, enjoy ur walk.